Tokai Pharmaceuticals Company Profile (NASDAQ:TKAI)

About Tokai Pharmaceuticals

Tokai Pharmaceuticals logoTokai Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapies for the treatment of prostate cancer and other hormonally-driven diseases. The Company's lead drug candidate, galeterone, is an oral small molecule that utilizes the mechanistic pathways of second-generation androgen signaling inhibitors, while also introducing a third mechanism-androgen receptor degradation. The Company develops galeterone for the treatment of patients with metastatic castration-resistant prostate cancer, or mCRPC. The Company is conducting a pivotal Phase III clinical trial comparing galeterone to Xtandi (enzalutamide) in approximately 148 treatment-naive mCRPC patients whose prostate tumors express the AR-V7 splice variant. The Company refers clinical trial as ARMOR3-SV, a precision-medicine based pivotal clinical trial in prostate cancer.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: TKAI
  • CUSIP:
Key Metrics:
  • Previous Close: $1.50
  • 50 Day Moving Average: $1.20
  • 200 Day Moving Average: $4.69
  • 52-Week Range: $0.98 - $12.93
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.19
  • P/E Growth: 0.01
  • Market Cap: $33.95M
  • Outstanding Shares: 22,634,000
  • Beta: 0.96
Profitability:
  • Return on Equity: -85.44%
  • Return on Assets: -76.47%
Debt:
  • Current Ratio: 5.91%
  • Quick Ratio: 5.91%
Additional Links:
Companies Related to Tokai Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Tokai Pharmaceuticals (NASDAQ:TKAI) (?)
Ratings Breakdown: 1 Sell Rating, 5 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $16.79 (1,019.17% upside)

Analysts' Ratings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Show:
DateFirmActionRatingPrice TargetDetails
8/24/2016BMO Capital MarketsReiterated RatingMarket Perform$1.70 -> $1.15View Rating Details
8/10/2016William BlairReiterated RatingNeutralView Rating Details
7/28/2016Bank of America Corp.DowngradeNeutral -> UnderperformView Rating Details
7/26/2016Stifel NicolausDowngradeBuy -> HoldView Rating Details
7/26/2016Janney Montgomery ScottDowngradeBuy -> NeutralView Rating Details
7/26/2016Wells Fargo & Co.DowngradeOutperform -> Market PerformView Rating Details
2/11/2016Oppenheimer Holdings Inc.Reiterated RatingOutperformView Rating Details
10/13/2014Jefferies GroupInitiated CoverageBuy$20.00View Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Tokai Pharmaceuticals (NASDAQ:TKAI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/12/2016        
5/10/2016Q1($0.50)($0.51)ViewN/AView Earnings Details
3/10/2016Q4($0.47)($0.49)ViewN/AView Earnings Details
11/10/2015Q3($0.53)($0.53)ViewN/AView Earnings Details
8/12/2015Q215($0.50)($0.40)ViewN/AView Earnings Details
5/12/2015Q115($0.31)($0.59)ViewN/AView Earnings Details
3/12/2015($0.40)($0.28)ViewN/AView Earnings Details
11/10/2014($0.42)($2.71)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Tokai Pharmaceuticals (NASDAQ:TKAI)
Current Year EPS Consensus Estimate: $-1.89 EPS
Next Year EPS Consensus Estimate: $-1.26 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.56)($0.56)($0.56)
Q2 20161($0.63)($0.63)($0.63)
Q3 20161($0.68)($0.68)($0.68)
Q4 20161($0.73)($0.73)($0.73)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tokai Pharmaceuticals (NASDAQ:TKAI)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tokai Pharmaceuticals (NASDAQ:TKAI)
Insider Ownership Percentage: 39.90%
Institutional Ownership Percentage: 23.81%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/15/2016Stephen Jr. BuckleyDirectorBuy8,000$5.74$45,920.00View SEC Filing  
11/11/2015Stephen Jr. BuckleyDirectorBuy3,000$11.25$33,750.00View SEC Filing  
9/21/2015John S. McbrideCOOSell13,500$14.01$189,135.00View SEC Filing  
9/8/2015Lee KalowskiCFOSell4,668$13.13$61,290.84View SEC Filing  
9/2/2015Lee KalowskiCFOSell2,158$12.96$27,967.68View SEC Filing  
7/15/2015Bioventures Ltd NovartisMajor ShareholderSell3,566$14.26$50,851.16View SEC Filing  
7/14/2015Bioventures Ltd NovartisMajor ShareholderSell27,861$14.41$401,477.01View SEC Filing  
7/13/2015Bioventures Ltd NovartisMajor ShareholderSell20,611$14.20$292,676.20View SEC Filing  
6/29/2015Jodie Pope MorrisonCEOSell16,000$13.77$220,320.00View SEC Filing  
6/24/2015John S McbrideCOOSell9,000$14.01$126,090.00View SEC Filing  
6/23/2015John S McbrideCOOSell6,700$14.00$93,800.00View SEC Filing  
6/22/2015John S McbrideCOOSell2,000$14.02$28,040.00View SEC Filing  
6/16/2015Bioventures Ltd NovartisMajor ShareholderSell1,120$14.27$15,982.40View SEC Filing  
6/11/2015Bioventures Ltd NovartisMajor ShareholderSell27,875$14.20$395,825.00View SEC Filing  
4/16/2015Lee KalowskiCFOSell4,567$13.00$59,371.00View SEC Filing  
4/2/2015Lee KalowskiCFOSell2,258$11.45$25,854.10View SEC Filing  
3/19/2015Bioventures Ltd NovartisMajor ShareholderSell49,141$14.50$712,544.50View SEC Filing  
9/22/2014Apple Tree Partners Ii - AnnexDirectorBuy237,500$15.00$3,562,500.00View SEC Filing  
9/22/2014Bioventures Ltd NovartisMajor ShareholderBuy325,000$15.00$4,875,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Tokai Pharmaceuticals (NASDAQ:TKAI)
DateHeadline
News IconMy Watchlist for Thursday, September 29 (NASDAQ:TKAI)
ac-investor.blogspot.com - September 28 at 7:27 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tokai Pharmaceuticals, Inc. (TKAI) and Lead Plaintiff Deadline: September 30, 2016 (NASDAQ:TKAI)
finance.yahoo.com - September 28 at 7:27 PM
finance.yahoo.com logo2-DAY DEADLINE ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 28 at 7:27 PM
News IconBiotech Stocks To Put On Your Watch List: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), Geron Corporation (NASDAQ ... - The Voice Registrar (NASDAQ:TKAI)
voiceregistrar.com - September 28 at 9:59 AM
News IconBiotech news that matter for investors: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), Vertex Pharmaceuticals ... - The Voice Registrar (NASDAQ:TKAI)
voiceregistrar.com - September 28 at 9:59 AM
News IconAnalysts Review: Dynavax Technologies Corporation (NASDAQ:DVAX), Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Newburgh Press (NASDAQ:TKAI)
newburghpress.com - September 28 at 9:59 AM
finance.yahoo.com logoSEPTEMBER 30 DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 27 at 7:38 PM
finance.yahoo.com logoTKAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving … (NASDAQ:TKAI)
finance.yahoo.com - September 27 at 12:14 PM
finance.yahoo.com logoTKAI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tokai Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of September 30, 2016 (NASDAQ:TKAI)
finance.yahoo.com - September 27 at 12:14 PM
finance.yahoo.com logo3-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 27 at 12:14 PM
News IconKeen Investors Find News on Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Duncan Research (NASDAQ:TKAI)
www.duncanindependent.com - September 23 at 7:03 PM
News IconTop Biotechnology Stock Picking: Navidea Biopharmaceuticals, Inc (NAVB), Tokai Pharmaceuticals, Inc. (TKAI) - The Independent Republic (NASDAQ:TKAI)
theindependentrepublic.com - September 23 at 7:03 PM
globenewswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of ... - GlobeNewswire (press release) (NASDAQ:TKAI)
globenewswire.com - September 23 at 7:03 PM
finance.yahoo.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Tokai Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 30, 2016 – TKAI (NASDAQ:TKAI)
finance.yahoo.com - September 23 at 7:03 PM
finance.yahoo.com logoONE WEEK DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 23 at 7:03 PM
News IconApptio, Inc. (Nasdaq: APTI) to Ring The Nasdaq Stock Market Opening Bell (NASDAQ:TKAI)
www.econotimes.com - September 23 at 9:37 AM
News IconSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Tokai Pha... (NASDAQ:TKAI)
ih.advfn.com - September 22 at 7:20 PM
finance.yahoo.com logoDEADLINE ALERT: Brower Piven Notifies Shareholders of September 30, 2016 Deadline In Class Action Lawsuit And Encourages Those With Losses In Excess of $100,000 From Investment In Tokai Pharmaceuticals, Inc. To Contact The Firm - TKAI (NASDAQ:TKAI)
finance.yahoo.com - September 22 at 7:20 PM
finance.yahoo.com logoSEPTEMBER 30 DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 22 at 7:20 PM
finance.yahoo.com logoDEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tokai Pharmaceuticals, Inc. (TKAI) and Lead Plaintiff Deadline - September 30, 2016 (NASDAQ:TKAI)
finance.yahoo.com - September 21 at 7:09 PM
finance.yahoo.com logoUPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 21 at 7:09 PM
News IconBiotech Top Losers in Focus- Tokai Pharmaceuticals (NASDAQ:TKAI), Cara Therapeutics (NASDAQ:CARA) - Seneca Globe (NASDAQ:TKAI)
www.senecaglobe.com - September 21 at 7:01 AM
finance.yahoo.com logoUPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 21 at 7:01 AM
News IconWhat is the Sell-side Saying About Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI)? - Frisco Fastball (NASDAQ:TKAI)
friscofastball.com - September 20 at 4:02 PM
News IconPenny Stock Investors Take an Interest in Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI) - Duncan Research (NASDAQ:TKAI)
www.duncanindependent.com - September 20 at 4:02 PM
News IconTrading the Biotech News: Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), Geron Corporation (NASDAQ:GERN) - The Voice Registrar (NASDAQ:TKAI)
voiceregistrar.com - September 20 at 4:02 PM
News IconTokai Pharmaceuticals, Inc. (TKAI) Quarterly Analysis - Newburgh Press (NASDAQ:TKAI)
newburghpress.com - September 20 at 4:02 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Tokai Pharmaceuticals, Inc. To Contact The Firm Before Lead Plaintiff Deadline (NASDAQ:TKAI)
finance.yahoo.com - September 20 at 4:02 PM
News IconBulls and Bear in Analyst's Spotlight- Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI), Neuralstem, Inc. (NASDAQ:CUR) - Seneca Globe (NASDAQ:TKAI)
www.senecaglobe.com - September 20 at 9:24 AM
News IconHC Stocks to Path! Tokai Pharmaceuticals Inc (TKAI), Endo International plc - Ordinary Shares (NASDAQ:ENDP) - share market updates (press release) (NASDAQ:TKAI)
sharemarketupdates.com - September 20 at 9:24 AM
News IconSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tokai Pharmaceuticals, Inc. of a Class Action Lawsuit & a L... (NASDAQ:TKAI)
ih.advfn.com - September 19 at 7:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tokai Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -- TKAI (NASDAQ:TKAI)
finance.yahoo.com - September 19 at 7:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Tokai Pharmaceuticals, Inc. (TKAI) and Lead Plaintiff Deadline - September 30, 2016 (NASDAQ:TKAI)
finance.yahoo.com - September 19 at 7:36 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Tokai Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 30, 2016 (NASDAQ:TKAI)
finance.yahoo.com - September 19 at 7:36 PM
finance.yahoo.com logoAPPROACHING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 19 at 7:36 PM
News IconHot Stock - Tokai Pharmaceuticals, Inc.'s (TKAI) - Hot Stocks Point (NASDAQ:TKAI)
www.hotstockspoint.com - September 18 at 9:45 AM
globenewswire.com logoDEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Tokai Pharmaceuticals, Inc. Of Upcoming Deadline - GlobeNewswire (press release) (NASDAQ:TKAI)
globenewswire.com - September 18 at 9:45 AM
News IconHere's my watchlist for the week ahead (NASDAQ:TKAI)
ac-investor.blogspot.com - September 17 at 9:40 AM
finance.yahoo.com logoDEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Tokai Pharmaceuticals, Inc. Of Upcoming Deadline (NASDAQ:TKAI)
finance.yahoo.com - September 16 at 7:23 PM
finance.yahoo.com logoEQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 16 at 7:23 PM
News IconTokai Pharmaceuticals, Inc. (NASDAQ:TKAI) Quarterly Analysis - Newburg Press (NASDAQ:TKAI)
newburghpress.com - September 16 at 11:14 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 16 at 11:14 AM
finance.yahoo.com logoTKAI ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors of Important September 30 Deadline in Class Action - TKAI (NASDAQ:TKAI)
finance.yahoo.com - September 16 at 11:14 AM
finance.yahoo.com logoWeissLaw LLP Announces Class Action Lawsuit Against Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI)
finance.yahoo.com - September 15 at 7:46 PM
News IconTKAI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Tokai Pharmaceuticals, Inc... (NASDAQ:TKAI)
ih.advfn.com - September 14 at 12:01 PM
finance.yahoo.com logoINVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Tokai Pharmaceuticals, Inc. and Reminds Investors with Losses In Excess of $100,000 to Contact the Firm (NASDAQ:TKAI)
finance.yahoo.com - September 14 at 12:01 PM
News IconWhat is the Street Saying About Tokai Pharmaceuticals, Inc. (NASDAQ:TKAI)? - Frisco Fastball (NASDAQ:TKAI)
friscofastball.com - September 13 at 9:43 AM
News IconShining Stocks in News Recap- Depomed (NASDAQ:DEPO), Tokai Pharmaceuticals (NASDAQ:TKAI), Hertz Global ... - Seneca Globe (NASDAQ:TKAI)
www.senecaglobe.com - September 11 at 9:58 AM
prnewswire.com logoINVESTOR ALERT: Rosen Law Firm Reminds Tokai Pharmaceuticals, Inc. Investors of Important September 30 ... - PR Newswire (press release) (NASDAQ:TKAI)
www.prnewswire.com - September 11 at 9:58 AM
News IconNews review of 2 biotech stocks: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Tokai Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:TKAI)
voiceregistrar.com - September 11 at 9:58 AM

Social

Tokai Pharmaceuticals (NASDAQ:TKAI) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff